A one-step diagnostic may bring faster, cheaper cancer testing to remote settings

August 05, 2020

Scientists have created a rapid and affordable test for breast cancer that is designed for use in developing regions, where patients often face delayed diagnoses that worsen their outcomes. The diagnostic showed an initial accuracy of 100% when tested in a small group of 68 patients, and could yield repeated results in less than 1 hour. Although more testing with large patient groups is necessary, the technique's speed and ease-of-use could help clinicians in resource-limited settings overcome barriers to rapid cancer diagnosis. Spotting cancers early on is challenging enough in developed countries, but it can be even more difficult in low- and middle-income countries, where more than two thirds of deaths from cancer occur. Due to the lack of medical infrastructure and healthcare specialists, diagnoses can be delayed for months and often come only after a patient has developed advanced disease. To address the need for new cancer tests, Jouha Min and colleagues harnessed image cytometry, a technique that images and analyzes individual cells for malignancy. They developed a compact and automated cytometry test named CytoPAN that studies breast cells gathered with fine-needle aspiration, a less invasive alternative to standard biopsies. In a validation study in South Korea, CytoPAN could be applied to 63 of 68 patients with breast cancer and spotted cancers with an accuracy of 100%, using as few as 50 cells per specimen. The test also spotted ER/PR and HER2, key cancer biomarkers, with an accuracy of 93% and 96%, respectively. The method offers several features for usability and affordability: it yields results quickly, integrates a simplified workflow that requires minimal training, and uses test kits with an estimated cost of only $5, more than five times cheaper than current diagnostics. The authors say future trials should test CytoPAN with a wider range of biomarkers and in other regions such as sub-Saharan Africa, where women with breast cancer face additional risks such as HIV infection.

American Association for the Advancement of Science

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.